McGregor et al., 2018 - Google Patents
Large Scale Production of Human Alpha Interferon from BacteriaMcGregor et al., 2018
- Document ID
- 12206239692649330976
- Author
- McGregor W
- Ramel A
- Publication year
- Publication venue
- Recombinant DNA Products
External Links
Snippet
This chapter provides some practical aspects of production in the three areas: fermentation, recovery, and purity analysis. The identity of recombinant interferon can be established not only by the antiviral or cytopathic effect inhibition assay but also at the genomic level …
- 102000006992 Interferon-alpha 0 title abstract description 11
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6399333B1 (en) | Process for producing erythropoietin containing no animal proteins | |
CN102482332B (en) | For obtaining the method and system of botulic neurotoxin | |
Ladisch et al. | Recombinant human insulin | |
CA1176980A (en) | Extraction of interferon from bacteria | |
JPH07224098A (en) | Interferon products derived from human blood | |
CN102666396A (en) | Methods and systems for purifying non-complexed botulinum neurotoxin | |
JP2721139B2 (en) | Animal interferon | |
US5196323A (en) | Process for preparing and purifying alpha-interferon | |
JPS63169995A (en) | Recovery and purification of beta-interferon | |
JPH05192143A (en) | Tocopherolcyclase | |
EP0446582B1 (en) | Method for producing of recombinant human cysteineless gamma-interferon free of methionine at n-terminal | |
JPH0671432B2 (en) | Method for producing human serum albumin | |
McGregor et al. | Large Scale Production of Human Alpha Interferon from Bacteria | |
CA1340281C (en) | Process for preparing and purifying alpha-interferon | |
CN104945490A (en) | Separated plant defensin polypeptide as well as preparation method and application thereof in treatment of lung cancer | |
CN109679941B (en) | Cordyceps militaris fibrinolytic enzyme and preparation method and application thereof | |
CN105802989B (en) | Vector, gene, method and application of recombinant protein expressed by pichia pastoris | |
EP1169461B1 (en) | Use of pancreatic procarboxypeptidase B for the production of insulin | |
CN111171144B (en) | Preparation and application of antibody for resisting porcine epidemic diarrhea virus | |
CN104418945A (en) | Preparation method of peptide and application of peptide in preparation of medicine and feed additive | |
RU2231545C1 (en) | Strain of yeast pichia pastoris ps105(pbig) as producer of bovine intracellular immune interferon, recombinant plasmid dna pbig providing biosynthesis of bovine intracellular immune interferon and method for constructing recombinant plasmid dna pbig | |
RU2355770C2 (en) | Method of producing anticoagulative protein, extracted from nematodes (nap) | |
CN100395263C (en) | Method for protein isolation in anoxic conditions | |
KR101113495B1 (en) | A method for purifying recombinant human Interferon beta | |
Kehoe | The story of biosynthetic human insulin |